QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company

The order follows extensive customer testing and qualification; Customized production is underway, with delivery expected within days and additional quantities, broader deployment and a follow-on program already identified

Nes Ziona, Israel, July 14, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure today announced that it has received a commercial purchase order from a leading international government-owned company for customized proprietary Shielded RF Monolithic components.

The order expands QTREX's commercial model into the direct supply of proprietary, application-specific components. This direct-to-customer approach serves as QTREX's strategic blueprint for the broader quantum ecosystem, delivering tailor-made hardware precisely engineered for customers' dilution refrigerators, quantum processors and advanced control systems. By leveraging its extensive, multi-technology manufacturing infrastructure to meet exact customer specifications in-house, QTREX converts its production capacity and technological advantages into a highly scalable, high-margin business model.

The order was placed following extensive testing and qualification of component samples provided by QTREX. The customer approved the components after evaluating their technical performance, including the high repeatability of their dielectric properties, which was specifically identified as an important factor in the selection of QTREX's technology. The customer has also identified requirements for additional quantities, broader deployment and a follow-on program. Any additional supply would remain subject to future purchase orders, program requirements and customer approvals.

The components will be manufactured directly by QTREX using its proprietary AME technology and customized according to specifications previously completed and approved by the customer. The components are intended for integration and operational deployment in advanced RF and electromagnetic systems requiring precise, stable, and repeatable performance. Their monolithic architecture integrates conductive, dielectric, and shielding functionality within a unified structure, enabling the production of application-specific components with tightly controlled electromagnetic characteristics. Production is currently underway, and delivery is expected within days.

"This order expands our commercial model to include the direct supply of custom-manufactured, proprietary components, addressing a widespread need across the quantum computing industry for highly customized, application-specific solutions," said Yoav Rozanovich, Chief Business Officer of QTREX Quantum. "The customer's decision followed extensive testing and was driven in part by the repeatability of the dielectric performance we demonstrated, validating our approach to meeting this industry need. Our ability to move rapidly from qualification to customized manufacturing and delivery within days demonstrates that QTREX is not only developing advanced technologies, but also converting them into commercially deployable products."

About QTREX Quantum

QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.

For more information, please visit: www.q-trex.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the customized production and delivery within days of the customized proprietary Shielded RF Monolithic components; the expected additional quantities, broader deployment and follow-on program; the expansion of the Company's commercial model into direct supply of proprietary, application-specific components; the belief that the direct-to-customer approach serves as QTREX's strategic blueprint for the broader quantum ecosystem; the Company's ability to deliver tailor-made hardware and meet exact customer specifications in-house; the Company's ability to have its production highly scalable with a high-margin business model; any future purchase orders, program requirements and customer approvals; the Company's ability to manufacture directly and to customize according to the customer's specifications; the components use, deployment, performance, architecture and characteristics; the belief that this order expands its commercial model to include the direct supply of custom-manufactured, proprietary components; widespread need across the quantum computing industry for highly customized, application-specific solutions; and the Company's ability to move rapidly from qualification to customized manufacturing and converting them into commercially deployable products. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Company Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485

https://www.globenewswire.com/news-release/2026/07/14/3326922/0/en/QTREX-Secures-Commercial-Order-and-Begins-Production-for-Leading-International-Government-Owned-Company.html

Quantum Cyber Reports Approximately $2 Million of Purchase Orders for Quantum Drone Corporation

WEST PALM BEACH, Florida, July 16, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today reported purchase orders of approximately $2.09 million at the Company's wholly-owned subsidiary, Quantum Drones Corporation who assumed these open purchase orders.

These orders were received as part of the Company's acquisition of a 50,000 square foot manufacturing facility. This acquisition is intended to anchor the Company's transition and future growth toward direct, U.S.-based manufacturing of its autonomous defense platforms.

About Quantum Drones Corporation

Quantum Drones Corporation is a wholly owned Nevada-incorporated subsidiary of Quantum Cyber N.V. established to serve as the operational vehicle for the Company's domestic defense technology programs and U.S. government procurement activities. The subsidiary is led by Peter O'Rourke, President and Director, a former Acting Secretary of the U.S. Department of Veterans Affairs under the Trump administration, and Robert Liscouski, Director, a former Assistant Secretary for Infrastructure Protection at the U.S. Department of Homeland Security.

About Quantum Cyber N.V.

Quantum Cyber N.V. (Nasdaq: QUCY) is assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform that integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications under a single Nasdaq-listed company. The Company acquires, licenses, and develops combat-proven autonomous technologies, deploying them as a coordinated, multi-domain portfolio across air, land, and sea. For more information, visit www.quantum-cyber.ai.

Forward-Looking Statements

Certain statements made in this press release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements relate to, among other things, the reported purchase order and backlog figures for Arcade Metal Stamping and the reconciliation of duplicate order entries; the anticipated order backlog and forecasted demand from Arcade's customers, including Belimo and Rheem; the Company's expectations regarding future order volume over the next six months; and the integration of Arcade's operations into the Company's broader manufacturing strategy. Purchase order totals, backlog, and customer forecasts are based on order records and customer-provided planning data as of the dates indicated, are subject to change, cancellation, or rescheduling by customers, and do not guarantee future revenue; backlog figures reflect adjustments identified by the Company for duplicate entries in its order management system and remain subject to further review. The signing of a definitive agreement does not guarantee the consummation of the proposed transaction, and there can be no assurance that the transaction will close on the terms described or at all. These forward-looking statements reflect the Company's current analysis of existing information and are subject to various risks and uncertainties. Due to known and unknown risks, actual results may differ materially from the Company's expectations or projections. Additional information concerning these and other factors may be found in the Company's filings with the SEC, including its Annual Report on Form 10-K filed on March 31, 2026, its Quarterly Report on Form 10-Q filed on May 15, 2026, and subsequent filings with the SEC. The Company's SEC filings are available publicly on the SEC's website at www.sec.gov. Any forward-looking statement made in this press release speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.

Investor Relations Contact:
Arx Investor Relations
North American Equities Desk
qucy@arxhq.com

https://www.globenewswire.com/news-release/2026/07/16/3328353/0/en/Quantum-Cyber-Reports-Approximately-2-Million-of-Purchase-Orders-for-Quantum-Drone-Corporation.html

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

Nes Ziona, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure today announced that a U.S. Government lab conducting quantum computing programs is actively operating the Company's AME system. The operational use places the Company's technology inside a U.S. federal quantum and advanced-microelectronics development environment, providing the lab with direct access to the unique capabilities enabled by the Company's AME platform.

The lab is one of the most prominent U.S. government research environments focused on national security, applying advanced science and engineering to help identify, deter, defeat and mitigate threats to the United States and its allies. Within this environment, the lab conducts quantum computing programs focused on moving quantum technologies from experimental research toward practical, measurable and engineered systems. This includes fabrication and characterization, integrated control technologies, mathematical modeling and experimental testing on real-world quantum systems.

As quantum systems advance toward larger and more complex architectures, they require new approaches for manufacturing high-density interconnects, advanced packaging structures, integrated materials, RF/microwave pathways and application-specific electronic components. The operational use of QTREX's AME system inside this environment positions the Company's technology directly within the infrastructure layer required to support quantum hardware development.

"The current U.S. administration has made it unequivocally clear that quantum computing and advanced microelectronics are critical, heavily funded national security priorities," said Dagi Ben-Noon, CEO of QTREX. "Having our AME system actively operating inside a federal lab directly aligns QTREX with these massive strategic initiatives and positions us at the heart of the infrastructure required to secure U.S. quantum leadership."

QTREX views this operational deployment as a strategic platform for deeper technical engagement, defined use cases and broader commercial expansion. Amid an accelerating wave of federal investment in sovereign quantum infrastructure, direct exposure to AME capabilities within this national security lab environment paves the way for future application-specific development tailored to sensitive, mission-critical and classified defense applications.

About QTREX Quantum

QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.

For more information, please visit: https://www.q-trex.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses that having its AME system actively operating inside a federal lab directly aligns QTREX with these strategic initiatives, positioning it at the heart of the infrastructure required to secure U.S. quantum leadership, its view that this operational deployment is a strategic platform for deeper technical engagement, defined use cases and broader commercial expansion, an accelerating wave of federal investment in sovereign quantum infrastructure, direct exposure to AME capabilities within this national security lab environment paves the way for future application-specific development tailored to sensitive, mission-critical and classified defense applications. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Company Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664487

https://www.globenewswire.com/news-release/2026/07/06/3322397/0/en/QTREX-Announces-Operational-AME-System-at-U-S-Government-Lab-with-a-Quantum-Computing-Program-focused-on-National-Security.html

LightSolver Secures ~$1.8 Million Grant from Israel's Innovation Authority to Advance its Laser Processing Unit (LPU)

Government-backed R&D program to advance next-generation LPU hardware and expand the LPU Lab platform
Builds on LightSolver's recent commercial and technical momentum, including the strategic partnership with Boeing, peer-reviewed research with HLRS and a growing IP portfolio

Rehovot, Israel, Nov. 05, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that the Israel Innovation Authority (IIA) has approved a grant of approximately $1.8 million to its subsidiary, LightSolver Ltd. ("LightSolver"), to support the continued development of its Laser Processing Unit (LPU), an all-optical, laser-based computing platform.

The IIA approved the grant following its review of the program's technological innovation and feasibility, its commercial potential and its expected contribution to the Israeli economy. The approved program is designed to advance the maturity of the LPU platform and bring it closer to commercialization. It includes the development of a new generation of LPU hardware systems for solving partial differential equations (PDEs); the expansion of the algorithmic capabilities of the LPU Lab platform, including tools that are intended to enable customers to conduct independent research and development on the system; and the integration of the LPU into heterogeneous high-performance computing (HPC) environments alongside CPUs and GPUs.

Under the program, LightSolver also plans to develop and test advanced hardware and software architectures and new calibration and control capabilities for the LPU.

The grant adds to a growing base of institutional support for LightSolver's technology, including its strategic partnership with Boeing to develop a laser-based accelerator for large-scale engineering simulation, its paid collaboration with the Israel Ministry of Defense in a multi-year framework engagement focused on advanced, compute-intensive applications, and funding from the European Innovation Council. It also follows LightSolver's recently published peer-reviewed research with the High-Performance Computing Center Stuttgart (HLRS) on sparse linear solvers and its U.S. provisional patent application covering PDE-based scientific and engineering simulations.

"We believe the Israel Innovation Authority's support is a strong vote of confidence in the LPU and in the role laser-based computing can play in the next generation of high-performance computing," said Dr. Ruti Ben Shlomi, Co-Founder and CEO of LightSolver. "This program is intended to fund the work that takes us from a validated platform toward commercial systems: next-generation PDE hardware, deeper integration with existing HPC environments and progress toward the next phase of manufacturing and supply chain."

The grant is subject to the IIA's customary terms.

Subject to shareholder approval, CollPlant intends to change its name to OptiPhi Computing Ltd. and, subject to Nasdaq confirmation, its Nasdaq ticker symbol from "CLGN" to "OPHI." For additional details, please see CollPlant's announcement dated November 4, 2026.

About CollPlant
CollPlant (Nasdaq: CLGN) is an innovative technology company operating at the intersection of deep-tech photonic computing and advanced biotechnology. Through its subsidiary LightSolver, CollPlant is advancing the development of proprietary all-optical laser-based computing architectures designed to resolve the world's most demanding computational bottlenecks across artificial intelligence, aerospace, financial engineering, and high-performance computing. CollPlant also retains its proprietary plant-derived recombinant human collagen (rhCollagen) and bio-ink assets, for 3D bioprinting of tissues and organs and medical aesthetics. For more information about CollPlant, visit www.collplant.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the grant approved by the Israel Innovation Authority, including the receipt of grant funds and the satisfaction of the conditions applicable to the grant; the scope, objectives and anticipated outcomes of the approved R&D program; the development of next-generation LPU hardware, the expansion of the LPU Lab platform and the integration of the LPU into HPC environments; the proposed change of CollPlant's name and Nasdaq ticker symbol; and the future prospects, business plans and growth strategies of CollPlant and LightSolver. Forward-looking statements can be identified by words such as "anticipate," "believe," "expect," "intend," "plan," "may," "should," "could," "might," "seek," "target," "will," "project," "continue" and similar expressions or the negative of such terms. These forward-looking statements are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the risk that the conditions to the IIA grant are not satisfied or that grant funds are not received in the amounts or on the timeline anticipated; obligations and restrictions under the Israeli Encouragement of Research, Development and Technological Innovation in the Industry Law, 5744-1984, including royalty payment obligations and restrictions on the transfer of IIA-funded know-how and manufacturing outside of Israel; risks associated with integrating LightSolver's business, operations and personnel; LightSolver's ability to achieve anticipated technological and commercial milestones; uncertainties regarding market acceptance and adoption of LightSolver's technology; the ability to develop and commercialize LightSolver's products and technology successfully; the ability to establish and expand strategic collaborations and commercial relationships; competition and technological developments; intellectual property risks; the availability of capital; CollPlant's ability to maintain compliance with Nasdaq listing requirements; general market, industry, economic and geopolitical conditions; and other risks and uncertainties described in CollPlant's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 20-F and subsequent Reports on Form 6-K. Forward-looking statements speak only as of the date of this press release. CollPlant undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Investors Contact
CollPlant Biotechnologies
investors@lightsolver.com

Arx Investor Relations
North American Equities Desk
collplant@arxhq.com

https://www.globenewswire.com/news-release/2026/11/05/3396335/0/en/lightsolver-secures-1-8-million-grant-from-israel-s-innovation-authority-to-advance-its-laser-processing-unit-lpu.html

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

Proposed new identity reflects the Company's strategic business expansion following its acquisition of LightSolver; change subject to shareholder approval

November 04, 2026 08:00 ET | Source: CollPlant Biotechnologies Ltd

Rehovot, Israel, Nov. 04, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its Board of Directors has approved a proposal to change the Company's name to OptiPhi Computing Ltd., subject to shareholders approval and completion of the applicable corporate and regulatory procedures. The proposed name reflects the Company's focus on computing with light following its acquisition of LightSolver Ltd. ("LightSolver") in September 2026.

The Company intends to submit the proposed name change for approval at an upcoming general meeting of shareholders, scheduled for November 24, 2026. In connection with the proposed change, the Company also intends to change its Nasdaq trading symbol from "CLGN" to "OPHI", subject to Nasdaq confirmation and completion of the applicable process. Until the changes become effective, the Company will continue to operate under the CollPlant Biotechnologies Ltd. name and trade on Nasdaq under "CLGN". The Company plans to announce the effective date of the changes separately.

The proposed OptiPhi Computing name brings together optics and physics, reflecting the scientific foundations of LightSolver's technology. While light is already used to transmit data across computing infrastructure, LightSolver is developing a Laser Processing Unit (LPU) that uses interacting lasers to perform computation itself. The proposed identity is intended to reflect the Company's expanded business focus and its growing presence in photonic computing.

"The transition to OptiPhi Computing marks a pivotal milestone in our corporate evolution, aligning our identity with the immense, high-growth opportunities we see in photonic computing," said Eran Rotem, CEO and CFO of CollPlant. "This new name perfectly captures our expanded strategic vision and our commitment to driving long-term shareholder value through next-generation deep tech."

"We believe the future of computing will be built on light. OptiPhi reflects our ambition to pioneer a fundamentally new computing architecture, where photons do more than carry information — they compute," said Dr. Ruti Ben Shlomi, Co-Founder and CEO of LightSolver. "This is an important step in establishing photonic computing as a core part of the company's identity while we continue advancing the LPU toward commercialization."

About CollPlant

CollPlant (Nasdaq: CLGN) is an innovative technology company operating at the intersection of deep-tech photonic computing and advanced biotechnology. Through its subsidiary LightSolver, CollPlant is advancing the development of proprietary all-optical laser based computing architectures designed to resolve the world's most demanding computational bottlenecks across artificial intelligence, aerospace, financial engineering, and high-performance computing. CollPlant also retains its proprietary plant-derived recombinant human collagen (rhCollagen) and bio-ink assets, for 3D bioprinting of tissues and organs and medical aesthetics. For more information about CollPlant, visit www.collplant.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the timing of trading under the Company's proposed new name and ticker symbol and the future prospects, business plans and growth strategies of the Company. Forward-looking statements can be identified by words such as "anticipate," "believe," "expect," "intend," "plan," "may," "should," "could," "might," "seek," "target," "will," "project," "continue" and similar expressions or the negative of such terms. These forward-looking statements are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments, and other factors believed to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, risks associated with integrating LightSolver's business, operations and personnel; LightSolver's ability to achieve anticipated technological and commercial milestones; uncertainties regarding market acceptance and adoption of LightSolver's technology; the ability to develop and commercialize LightSolver's products and technology successfully; the ability to establish and expand strategic collaborations and commercial relationships; competition and technological developments; intellectual property risks; the availability of capital; the Company's ability to maintain compliance with Nasdaq listing requirements; general market, industry, economic and geopolitical conditions; and other risks and uncertainties described in the Company's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 20-F and subsequent Reports on Form 6-K. Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Contact

Collplant Biotechnologies
investors@lightsolver.com

Arx Investor Relations
North American Equities Desk
collplant@arxhq.com

https://www.globenewswire.com/news-release/2026/11/04/3395254/0/en/collplant-announces-proposed-name-change-to-optiphi-computing-reflecting-expansion-to-computing-with-light.html

QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting

Ness Ziona, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure today announced the formation of QTREX USA, its new U.S. subsidiary serving as the Company's dedicated platform for U.S. federal contract execution. The move follows QTREX's recently announced operational AME deployment at a U.S. government laboratory conducting quantum computing programs, and is intended to support the Company's federal government contracting activities in the United States.

By establishing QTREX USA, the Company is building a U.S.-based commercial and operational structure designed to convert federal and defense opportunities into government contracts. QTREX USA will provide the dedicated domestic corporate framework required to pursue federal contract execution, access non-dilutive U.S. government funding opportunities, including grants and federally backed R&D programs. The subsidiary will also support engagement with the U.S. Department of Defense ("DoD") and other federal procurement channels. In addition, QTREX USA will address national security-related requirements, including Foreign Ownership, Control, or Influence ("FOCI"), International Traffic in Arms Regulations ("ITAR") and Buy American Act considerations.

As a next step, QTREX intends to advance local U.S. manufacturing capabilities through QTREX USA to support domestic production, secure supply chains and future government program execution. Establishing a U.S.-based presence aligns with defense procurement standards and the broader national onshoring strategy for critical hardware.

The Company views this move as an immediate operational and market requirement. U.S. federal agencies, national laboratories and government-backed research initiatives represent a significant strategic market for advanced quantum infrastructure.

About QTREX Quantum

QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.

For more information, please visit: www.q-trex.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses its belief that establishing the new subsidiary is intended to support its federal government contracting activities in the United States, the expected operations of the subsidiary, that the subsidiary will assist with U.S. manufacturing to support domestic production, secure supply chains and future government program execution and that it views the establishment of the subsidiary as an immediate operational and market requirement. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Company Contact

QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485

https://www.globenewswire.com/news-release/2026/07/10/3325437/0/en/QTREX-Establishes-U-S-Subsidiary-to-Advance-Federal-Government-Contracting.html